Search results

  1. Inotersen for treating hereditary transthyretin amyloidosis (HST9)

    Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis

  2. Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (HST12)

    Evidence-based recommendations on cerliponase alfa (Brineura) for treating neuronal ceroid lipofuscinosis type 2 in children

  3. Antenatal care

    In development [GID-NG10096] Expected publication date: 11 August 2021

  4. Pernicious anaemia

    In development [GID-NG10176] Expected publication date: 23 March 2023

  5. Acne Vulgaris: Management

    In development [GID-NG10109] Expected publication date: 09 June 2021

  6. Diabetes update

    In development [GID-NG10152] Expected publication date: TBC

  7. Shared decision making

    In development [GID-NG10120] Expected publication date: 17 June 2021

  8. Postnatal care

    In development [GID-NG10070] Expected publication date: 07 April 2021

  9. Weight Management

    In development [GID-NG10182] Expected publication date: 22 June 2022